Picard Medical (PMI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
16 Jul, 2026Executive summary
Annual Meeting scheduled for July 17, 2026, at 3:00 p.m. Mountain Time, to be held virtually.
Proxy materials and voting instructions are available online for shareholder review.
Stockholders are encouraged to vote using their provided control numbers and instructions.
Voting matters and shareholder proposals
Proxy materials detail the matters to be voted upon at the Annual Meeting.
Voting can be completed online prior to or during the virtual meeting.
Shareholder rights and capital structure
Stockholders receive unique control numbers for secure voting access.
Assistance is available for shareholders who have not received voting materials.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Picard Medical
- A 500,000-share resale registration pairs an established artificial heart with dilution and listing risks.PMI
Registration filing - A proven bridge-to-transplant heart anchors a pipeline toward fully implantable support.PMIInvestor presentation
- Shareholders face votes on a $5 million placement and an expanded equity incentive plan.PMIProxy filing
- A 500,000-share resale registration overlays dilution and listing risks on an established artificial-heart platform.PMIRegistration filing
- Revenue up 50% to $4.1M, net loss widens, going concern and customer risks persist.PMIQ2 2026
- Proxy supplement corrects voting options and updates Audit Committee details for the 2026 meeting.PMIProxy filing
- Key proposals include director elections, reverse stock split, and creation of high-vote Class B stock.PMIProxy filing
- Proxy seeks approval for director elections, reverse split, new Class B stock, and auditor ratification.PMIProxy filing
- Q1 2026 revenue jumped 85% to $1.2M, but losses and NYSE compliance risks persist.PMIQ1 2026